Acute Intermediate-Risk PE Case Study: EKOS Therapy with a Low-Dose OPTALYSE Protocol Without Use of Contrast

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Acute Intermediate-Risk PE Case Study: EKOS Therapy with a Low-Dose OPTALYSE Protocol Without Use of Contrast

By Boston Scientific FEATURING Anas Safadi

0 views

July 6, 2022

Anas Safadi, MD, ABVM, FACC, FSCAI reviews technique for EKOS device placement without the use of contrast.

Comments 0

Impact of Real-World Evidence on Pulmonary Embolism Treatment Options

Feat. M. Jaff, A. Safadi, P. Troy

27:07

Boston Scientific

Advanced Endovascular Management of Pulmonary Embolism: What Does RE…

Feat. P. Monteleone

15:10

Boston Scientific

TCT 2023: REAL-PE: New Perspectives on Endovascular Strategies for P…

Feat. M. Jaff, P. Monteleone, R. Ahern, J. Mirviss, S. Parikh

12:07

Boston Scientific

Case Study: Pulmonary Embolism Treatment with EKOS+, A Contemporary …

Feat. A. Safadi

Boston Scientific

EKOS Endovascular System: The OPTALYSE Trial Results

Boston Scientific

EKOS Endovascular System: The SEATTLE II Trial Results

Boston Scientific

EKOS Endovascular System: The ULTIMA Trial Results